Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Inflammatory Bowel Diseases

Free Subscription 27.06.2022 6 Aliment Pharmacol Ther 4 Clin Gastroenterol Hepatol 1 Clin Res Hepatol Gastroenterol 1 Dig Dis Sci 2 Dis Colon Rectum 1 Gastroenterology 4 Inflamm Bowel Dis 2 Lancet Gastroenterol Hepatol 1 PLoS Comput Biol 2 PLoS One 2 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. MASSIRONI S, Vigano C, Danese S
   Letter: pancreatic involvement in inflammatory bowel disease-authors' reply.
   Aliment Pharmacol Ther. 2022;56:371.
   PubMed        
   
   
2. DAI C, Huang YH
   Letter: pancreatic involvement in inflammatory bowel disease.
   Aliment Pharmacol Ther. 2022;56:370.
   PubMed        
   
   
3. SOLITANO V, Armuzzi A
   Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine?
   Aliment Pharmacol Ther. 2022;56:347-348.
   PubMed        
   
   
4. FRIEDMAN S
   Editorial: measuring fertility in men with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2022;56:345-346.
   PubMed        
   
   
5. GILL M, Majumdar A
   Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game.
   Aliment Pharmacol Ther. 2022;56:353-354.
   PubMed        
   
   
6. KO KL, Hung IF, Leung WK
   Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game. Authors' reply.
   Aliment Pharmacol Ther. 2022;56:355-356.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

7. BATTAT R, Sandborn WJ
   Advances in the Comprehensive Management of Postoperative Crohn's Disease.
   Clin Gastroenterol Hepatol. 2022;20:1436-1449.
   PubMed         Abstract available
   
   
8. NARULA N, Wong ECL, Dulai PS, Sengupta NK, et al
   Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease.
   Clin Gastroenterol Hepatol. 2022;20:1579-1587.
   PubMed         Abstract available
   
   
9. AKIYAMA S, Rodriguez TG, Rubin DT
   Stratifying Risks of Ileal Pouch Outcomes.
   Clin Gastroenterol Hepatol. 2022;20:1620-1621.
   PubMed        
   
   
10. JENA A, James D, Singh AK, Dutta U, et al
    Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.
    Clin Gastroenterol Hepatol. 2022;20:1456-1479.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

11. NAYAGAM JS, Mandour MO, Taylor A, Heneghan MA, et al
    Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022 Jun 18:101980.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

12. GU D, Cao T, Yi S, Liu Y, et al
    CCCTC-Binding Factor Mediates the Transcription of Insulin-Like Growth Factor Binding Protein 5 Through EZH2 in Ulcerative Colitis.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07566.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

13. KOSARAJU RS, Wong DJ, Roth EM, Cataldo TE, et al
    Dose-Intensified Infliximab Rescue Therapy for Severe Ulcerative Colitis Does not Reduce Short-term Colectomy Rates or Increase Postoperative Complications.
    Dis Colon Rectum. 2021 Dec 13. pii: 00003453-900000000-99221.
    PubMed         Abstract available
    
    
14. OLECKI EJ, Perez Hoguin RA, King S, Razavi N, et al
    High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy.
    Dis Colon Rectum. 2021 Dec 27. pii: 00003453-900000000-99206.
    PubMed         Abstract available
    
    

    
    Gastroenterology

15. MURAMOTO Y, Nihira H, Shiokawa M, Izawa K, et al
    Anti-integrin alphavbeta6 antibody as a diagnostic marker for pediatric patients with ulcerative colitis.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00631.
    PubMed        
    
    

    
    Inflamm Bowel Dis

16. LIU E, Laube R, Leong RW, Fraser A, et al
    Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making.
    Inflamm Bowel Dis. 2022 Jun 17. pii: 6609865. doi: 10.1093.
    PubMed         Abstract available
    
    
17. ARJOMAND FARD N, Armstrong H, Perry T, Wine E, et al
    Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617562. doi: 10.1093.
    PubMed         Abstract available
    
    
18. INNOCENTI T, Bigagli E, Lynch EN, Galli A, et al
    MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617564. doi: 10.1093.
    PubMed         Abstract available
    
    
19. SEDANO R, Hogan M, Zou G, Narula N, et al
    Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617565. doi: 10.1093.
    PubMed        
    
    

    
    Lancet Gastroenterol Hepatol

20. ANANTHAKRISHNAN AN, Kaplan GG, Bernstein CN, Burke KE, et al
    Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus.
    Lancet Gastroenterol Hepatol. 2022;7:666-678.
    PubMed         Abstract available
    
    
21. MEIMA-VAN PRAAG EM, van Rijn KL, Wasmann KATGM, Snijder HJ, et al
    Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Lancet Gastroenterol Hepatol. 2022;7:617-626.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

22. JANSEN JE, Aschenbrenner D, Uhlig HH, Coles MC, et al
    A method for the inference of cytokine interaction networks.
    PLoS Comput Biol. 2022;18:e1010112.
    PubMed         Abstract available
    
    

    
    PLoS One

23. WANG J, Kou F, Han X, Shi L, et al
    Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis.
    PLoS One. 2022;17:e0270297.
    PubMed         Abstract available
    
    
24. OZAKA S, Sonoda A, Ariki S, Minata M, et al
    Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    PLoS One. 2022;17:e0269698.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

25. BAUER N, Kairey L, Schlee C, Uecker C, et al
    Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
    Scand J Gastroenterol. 2022 Jun 18:1-7. doi: 10.1080/00365521.2022.2078667.
    PubMed         Abstract available
    
    
26. KOUKI M, Caron B, Malgras A, Ayav A, et al
    Weight change after colectomy for ulcerative colitis.
    Scand J Gastroenterol. 2022 Jun 20:1-3. doi: 10.1080/00365521.2022.2089537.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: